Toth Financial Advisory’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-2,000
Closed -$48.7K – 737
2023
Q4
$48.7K Hold
2,000
– – 0.01% 301
2023
Q3
$44.8K Hold
2,000
– – 0.01% 286
2023
Q2
$51.2K Hold
2,000
– – 0.01% 268
2023
Q1
$47.3K Hold
2,000
– – 0.01% 280
2022
Q4
$43.6K Hold
2,000
– – 0.01% 290
2022
Q3
$49K Hold
2,000
– – 0.01% 275
2022
Q2
$54K Hold
2,000
– – 0.01% 261
2022
Q1
$78K Hold
2,000
– – 0.01% 248
2021
Q4
$92K Hold
2,000
– – 0.01% 241
2021
Q3
$95K Hold
2,000
– – 0.01% 246
2021
Q2
$93K Hold
2,000
– – 0.01% 225
2021
Q1
$88K Hold
2,000
– – 0.01% 239
2020
Q4
$82K Hold
2,000
– – 0.01% 227
2020
Q3
$75K Buy
+2,000
New +$73.7K 0.01% 220

Other funds holding FFTY

Toth Financial Advisory's FFTY Position: Q1 2024 in Review

Toth Financial Advisory sold out of CapForce IBD 50 ETF (FFTY) in Q1 2024, closing a stake of 2,000 shares — an estimated $48.7K sold.

Toth Financial Advisory first reported a position in FFTY in Q3 2020 and held it in 14 quarters. The position peaked at $95K in Q3 2021. 40 funds tracked by Wall St. Rank hold FFTY as of Q1 2024.

  • Toth Financial Advisory reported no remaining CapForce IBD 50 ETF position as of Q1 2024 after selling out during the quarter.
  • Toth Financial Advisory sold 2,000 CapForce IBD 50 ETF shares in Q1 2024, an estimated $48.7K.
  • Toth Financial Advisory first reported a position in CapForce IBD 50 ETF in Q3 2020 and held it in 14 quarters.
  • Toth Financial Advisory's CapForce IBD 50 ETF position peaked at $95K in Q3 2021.
  • 40 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2024.

Based on Toth Financial Advisory's 13F filing for Q1 2024, filed 16 Apr 2024.